Jeff Lee, CEO, mProve Health, was recently featured in the May issue of Prostatepedia, a monthly periodical featuring conversations with leading medical experts in the prostate cancer world. He discusses how mobile technology affects oncology clinical trials and explains what mHealth applications can do for cancer patients in research studies.
Demonstrating Profitability for the Seventh Consecutive Year, mProve Health Moves Growing Team into New Headquarter Offices
WASHINGTON, DC – May 22, 2017, mProve Health, a leading provider of mobile technologies used by life science organizations to connect and engage patients with global clinical research studies, announces unprecedented 12-month growth and the addition of 25% more new pharmaceutical companies and CROs to its client base.
Check out this feature in BioPharma Dive on how mProve Health’s mobile technology is helping patients who participate in clinical trials. CSO Denis Curtin weighs in on the mobile evolution in pharma and how mCast SMS recruiting helped us become industry leaders. To read the full article, click here.
Bioclinica announced the selection of mProve Health as an eHealth App xChange technology partner. mProve’s mobile-device enabled patient engagement solutions work alongside Bioclinica’s platform to improve the experience of clinical trial participants. To read the full press release click here.
BYOD has been a buzzword in the clinical trial space since mProve Health got started in 2010. We have seen the movement go from risky and heavily-hyped to a conservatively accepted. From our start in ePRO, we’ve been driving the BYOD bandwagon. Now, though, we want to pull over and ask for directions. That stopover is CYOD.